Aethlon Medical (NASDAQ:AEMD) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMDGet Rating) in a research report sent to investors on Saturday morning. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, Maxim Group decreased their price objective on Aethlon Medical from $11.00 to $4.00 in a research note on Tuesday, February 15th.

Shares of AEMD opened at $1.46 on Friday. Aethlon Medical has a 1 year low of $0.88 and a 1 year high of $12.49. The firm has a market cap of $22.50 million, a PE ratio of -2.43 and a beta of 0.81. The stock’s fifty day moving average price is $1.26 and its two-hundred day moving average price is $1.67.

A number of hedge funds and other institutional investors have recently made changes to their positions in AEMD. BlackRock Inc. increased its stake in Aethlon Medical by 771.7% in the 3rd quarter. BlackRock Inc. now owns 73,074 shares of the medical equipment provider’s stock worth $282,000 after acquiring an additional 64,691 shares during the last quarter. Geode Capital Management LLC increased its stake in Aethlon Medical by 32.3% in the 3rd quarter. Geode Capital Management LLC now owns 136,451 shares of the medical equipment provider’s stock worth $526,000 after acquiring an additional 33,330 shares during the last quarter. Renaissance Technologies LLC purchased a new position in shares of Aethlon Medical in the 3rd quarter worth about $196,000. Dimensional Fund Advisors LP purchased a new position in shares of Aethlon Medical in the 3rd quarter worth about $397,000. Finally, Jane Street Group LLC purchased a new position in shares of Aethlon Medical in the 3rd quarter worth about $101,000. Institutional investors and hedge funds own 10.58% of the company’s stock.

About Aethlon Medical (Get Rating)

Aethlon Medical, Inc, a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system.

Recommended Stories

Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.